I wouldn't be so concerned with the revenue as it was a timing issue. Also with the margins increasing it is apparent that they have some competitive advantage in play. With the SP at 5 YR lows there is limited downside risk plus a floor is in place due to the cash backing on the balance sheet. Finally Mr. Market is being kind offering a supply of undervalued stock due to short-termism. Overall a very favorable risk:reward trade into 2018 with YOW gaining further revenue traction and market share.
- Forums
- ASX - By Stock
- YOW
- Ann: Change of Director's Interest Notice
YOW
yowie group ltd
Add to My Watchlist
0.00%
!
1.4¢

Ann: Change of Director's Interest Notice, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.211M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
YOW (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online